BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35567633)

  • 1. The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid and pleomorphic LCIS.
    Brogi E
    Virchows Arch; 2022 Dec; 481(6):823-837. PubMed ID: 35567633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive lobular neoplasia of the breast: Morphologic features, clinical presentation, and management dilemmas.
    Calle C; Kuba MG; Brogi E
    Breast J; 2020 Jun; 26(6):1148-1155. PubMed ID: 32500575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upgrade Rates of Variant Lobular Carcinoma In Situ Compared to Classic Lobular Carcinoma In Situ Diagnosed in Core Needle Biopsies: A 10-Year Single Institution Retrospective Study.
    Harinath L; Villatoro TM; Clark BZ; Fine JL; Yu J; Carter GJ; Diego E; McAuliffe PF; Mai P; Lu A; Zuley M; Berg WA; Bhargava R
    Mod Pathol; 2024 Apr; 37(4):100462. PubMed ID: 38428736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lobular carcinoma in situ: diagnostic criteria and molecular correlates.
    Sokolova A; Lakhani SR
    Mod Pathol; 2021 Jan; 34(Suppl 1):8-14. PubMed ID: 33024303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes.
    Singh K; Paquette C; Kalife ET; Wang Y; Mangray S; Quddus MR; Steinhoff MM
    Hum Pathol; 2018 Aug; 78():163-170. PubMed ID: 29753007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ.
    Nakhlis F; Harrison BT; Giess CS; Lester SC; Hughes KS; Coopey SB; King TA
    Ann Surg Oncol; 2019 Jan; 26(1):55-61. PubMed ID: 30362065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Lobular Neoplasia Diagnosed by Core Biopsy.
    Jani C; Lotz M; Keates S; Gupta Y; Walker A; Al Omari O; Parvez A; Patel D; Gnata M; Perry J; Khorashadi L; Weissmann L; Pories SE
    Breast J; 2023; 2023():8185446. PubMed ID: 37114120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.
    Elsheikh TM; Silverman JF
    Am J Surg Pathol; 2005 Apr; 29(4):534-43. PubMed ID: 15767810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature.
    Foschini MP; Miglio R; Fiore R; Baldovini C; Castellano I; Callagy G; Bianchi S; Kaya H; Amendoeira I; Querzoli P; Poli F; Scatena C; Cordoba A; Pietribiasi F; Kovács A; Faistova H; Cserni G; Quinn C
    Eur J Surg Oncol; 2019 Dec; 45(12):2279-2286. PubMed ID: 31301938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobular Carcinoma In Situ during Preoperative Biopsy and the Rate of Upgrade.
    Lee J; Ku GY; Lee H; Park HS; Ku JS; Kim JY; Park S; Park BW
    Cancer Res Treat; 2022 Oct; 54(4):1074-1080. PubMed ID: 34942684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications.
    Sullivan ME; Khan SA; Sullu Y; Schiller C; Susnik B
    Arch Pathol Lab Med; 2010 Jul; 134(7):1024-8. PubMed ID: 20586632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Concepts in Diagnosis, Molecular Features, and Management of Lobular Carcinoma In Situ of the Breast With a Discussion of Morphologic Variants.
    Ginter PS; D'Alfonso TM
    Arch Pathol Lab Med; 2017 Dec; 141(12):1668-1678. PubMed ID: 28574280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lobular Neoplasia.
    Lunt L; Coogan A; Perez CB
    Surg Clin North Am; 2022 Dec; 102(6):947-963. PubMed ID: 36335930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
    Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
    Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Core Breast Biopsies Showing Lobular Carcinoma In Situ Should Be Excised and Surveillance Is Reasonable for Atypical Lobular Hyperplasia.
    Sen LQ; Berg WA; Hooley RJ; Carter GJ; Desouki MM; Sumkin JH
    AJR Am J Roentgenol; 2016 Nov; 207(5):1132-1145. PubMed ID: 27532153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lobular Carcinoma In Situ.
    Wen HY; Brogi E
    Surg Pathol Clin; 2018 Mar; 11(1):123-145. PubMed ID: 29413653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ.
    Simpson PT; Gale T; Fulford LG; Reis-Filho JS; Lakhani SR
    Breast Cancer Res; 2003; 5(5):258-62. PubMed ID: 12927036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Do We Approach Benign Proliferative Lesions?
    Nakhlis F
    Curr Oncol Rep; 2018 Mar; 20(4):34. PubMed ID: 29572753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for women with lobular carcinoma in situ (LCIS).
    Oppong BA; King TA
    Oncology (Williston Park); 2011 Oct; 25(11):1051-6, 1058. PubMed ID: 22106556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy.
    Shin SJ; Rosen PP
    Arch Pathol Lab Med; 2002 Jun; 126(6):697-701. PubMed ID: 12033958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.